4.10
Koru Medical Systems Inc stock is traded at $4.10, with a volume of 149.64K.
It is down -0.97% in the last 24 hours and down -0.24% over the past month.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
See More
Previous Close:
$4.14
Open:
$4.18
24h Volume:
149.64K
Relative Volume:
0.98
Market Cap:
$188.33M
Revenue:
$41.13M
Net Income/Loss:
$-2.64M
P/E Ratio:
-71.68
EPS:
-0.0572
Net Cash Flow:
$-494.10K
1W Performance:
+5.13%
1M Performance:
-0.24%
6M Performance:
-14.23%
1Y Performance:
+50.74%
Koru Medical Systems Inc Stock (KRMD) Company Profile
Name
Koru Medical Systems Inc
Sector
Industry
Phone
845-469-2042
Address
100 CORPORATE DRIVE, MAHWAH, NY
Compare KRMD vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
KRMD
Koru Medical Systems Inc
|
4.10 | 190.16M | 41.13M | -2.64M | -494.10K | -0.0572 |
|
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Koru Medical Systems Inc Stock (KRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Sep-07-23 | Initiated | B. Riley Securities | Buy |
| Sep-07-23 | Initiated | Lake Street | Buy |
| Nov-10-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-10-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-26-21 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-26-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-10-20 | Initiated | H.C. Wainwright | Buy |
| Jul-16-20 | Initiated | Canaccord Genuity | Buy |
| Jun-24-20 | Initiated | Piper Sandler | Overweight |
View All
Koru Medical Systems Inc Stock (KRMD) Latest News
KRMD Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Operational DisciplineOperating Margin Analysis - Newser
MDR Certification Granted to KORU Medical for Freedom60 Infusion Pump - Medical Product Outsourcing
KORU Medical (NASDAQ: KRMD) backs directors, equity plan and auditor - Stock Titan
Koru Medical CEO Linda Tharby buys $4,668 in company stock By Investing.com - Investing.com Nigeria
Koru Medical Systems CTO Eric Schiller buys $19,562 of stock By Investing.com - Investing.com South Africa
Insider Buying: Eric Schiller Acquires Shares of KORU Medical Sy - GuruFocus
Koru Medical Systems CTO Eric Schiller buys $19,562 of stock - Investing.com
Koru Medical CEO Linda Tharby buys $4,668 in company stock - Investing.com India
KORU Medical (KRMD) CTO acquires 5,000 shares in open-market buy - Stock Titan
KORU Medical (KRMD) CEO adds 1,191 shares in open-market buy - Stock Titan
KORU Medical (KRMD) CEO Linda Tharby adds 1,191 shares in open-market buy - Stock Titan
KRMD Stock Price, Quote & Chart | KORU MEDICAL SYSTEMS INC (NASDAQ:KRMD) - ChartMill
KORU Medical (KRMD) CEO reports RSU vesting and tax-withheld shares - Stock Titan
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress - BioSpace
KORU Medical presents research on subcutaneous infusion system - Investing.com UK
KORU Medical Systems (KRMD) COO logs RSU vesting and share withholding for taxes - Stock Titan
KORU Medical Systems (KRMD) COO buys 5,000 shares in open-market trade - Stock Titan
KORU Medical (KRMD) CFO reports RSU vesting with 2,900 shares withheld - Stock Titan
KORU Medical Systems (KRMD) CFO buys 5,500 shares in open market - Stock Titan
KORU Medical presents research on subcutaneous infusion system By Investing.com - Investing.com Australia
Nurses report less strain, high satisfaction with KORU’s FreedomEDGE pump - Stock Titan
[144] KORU Medical Systems, Inc. SEC Filing - Stock Titan
About Us | Oil & Gas JournalKORU Medical Systems, Inc.Common Stock (Nasdaq:KRMD) Stock Quote - FinancialContent
TradingKey - tradingkey.com
KORU Medical Systems (NASDAQ:KRMD) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
May 2026 Penny Stocks Worth Watching - simplywall.st
KORU Medical Systems Reports 22% Revenue Growth in Q1 2026 - HarianBasis.co
KORU Medical Systems Q1 2026 revenue up 22% to USD 11.8M - Medical Buyer
Koru Medical (KRMD) Q1 2026 Earnings Transcript - AOL.com
KORU Medical Q1 2026 slides: 22% revenue growth beats forecast By Investing.com - Investing.com Australia
KORU targets $47.5M-$50M 2026 revenue while planning next-gen Freedom60 510(k) and MDR submissions - MSN
Piper Sandler Maintains KORU Medical Systems(KRMD.US) With Hold Rating, Maintains Target Price $5 - Moomoo
Number of shareholders of KORU Medical Systems, Inc. – NASDAQ:KRMD - TradingView
KORU Medical Systems Announces First Quarter 2026 Results - BioSpace
KORU Medical Systems, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:KRMD) 2026-05-07 - Seeking Alpha
KORU Medical Systems (NASDAQ:KRMD) Announces Earnings Results, Meets Estimates - MarketBeat
KORU Medical Systems Q1 Earnings Call Highlights - MarketBeat
KORU Medical Q1 2026 slides: 22% revenue growth beats forecast - Investing.com
KORU Medical Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: KORU Medical Q1 2026 beats revenue forecasts - Investing.com
Earnings call transcript: KORU Medical Q1 2026 beats revenue forecasts By Investing.com - Investing.com Australia
Q1 2026 KORU Medical Systems Inc Earnings Call Transcript - GuruFocus
KORU seeks new infusion use as two drug trials reach Phase III - Stock Titan
Press Release: KORU Medical Systems Announces First Quarter 2026 Results - Moomoo
KORU Medical Systems (NASDAQ: KRMD) posts 22% Q1 2026 revenue growth - Stock Titan
KORU Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
KORU Medical (NASDAQ: KRMD) Q1 2026 revenue jumps 22% as guidance held - Stock Titan
Why KORU (KRMD) is trading below its true worth (-1.72%) 2026-05-06Trending Stock Ideas - newser.com
KORU Medical Systems Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
We Think KORU Medical Systems (NASDAQ:KRMD) Can Easily Afford To Drive Business Growth - Yahoo Finance
Koru Medical Systems Inc Stock (KRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):